American Oncology Network Inc. Cash Flow-to-Debt Ratio

Latest as of December 2024: 0.03x

American Oncology Network Inc. cash flow-to-debt ratio. American Oncology Network Inc. (AONC) has a Cash Flow-to-Debt Ratio of 0.03x as of December 2024, meaning its operating cash flow of $11.93 Million could theoretically repay 0% of its total liabilities ($362.32 Million) in one year. Check AONC capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

CF-to-Debt Ratio

0.03x
Operating CF / Total Liabilities

Operating Cash Flow

$11.93 Million
USD

Total Liabilities

$362.32 Million
USD

Data as of

Dec 2024
Most recent filing

Cash Flow-to-Debt Ratio of American Oncology Network Inc. (2020–2024)

Cash flow-to-debt ratio of American Oncology Network Inc. from 2020 to 2024. Historical debt coverage capacity for American Oncology Network Inc. across 5 annual periods. Check AONC cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

American Oncology Network Inc. Cash Flow-to-Debt Ratio by Year (2020–2024)

American Oncology Network Inc. cash flow-to-debt ratio by year from 2020 to 2024. Year-by-year debt coverage analysis for American Oncology Network Inc.. For the full cash flow conversion analysis, see American Oncology Network Inc. (AONC) cash flow conversion.

Year CF-to-Debt Ratio Operating CF (USD) Total Liabilities YoY Change
2024 -0.01x $-4.94 Million $362.32 Million ▲ +77.1%
2023 -0.06x $-18.12 Million $303.74 Million ▼ -132.3%
2022 -0.03x $-6.78 Million $264.21 Million ▲ +53.6%
2021 -0.06x $-1.23 Million $22.26 Million ▼ -100.0%
2020 1497.65x $37.24 Million $24.87K —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.